Eunji Jo

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma”.

A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2566

N/A

1.3DataRank · unranked

43 citations

Hee-Jin Jang, Maheshwari Ramineni, Daniel Wang, Daniela Ramos, Jong Min Choi +10 more

Satisfaction with mode of delivery of genomic sequencing results in a diverse national sample of research participants through the Clinical Sequencing Evidence-Generating Research Consortium

Genetics in Medicine(2024)10.1016/j.gim.2024.101176

N/A

0DataRank · unranked

3 citations

Jill O. Robinson, Eunji Jo, Sabrina A. Suckiel, Laura M. Amendola, Ann Katherine M. Foreman +5 more